| Patent | Date |
|---|
Substituted 4-aminoisoindoline-1,3-dione Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20220306611 - Alexander; Matthew D. ; et al. | 2022-09-29 |
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith
Grant 11,358,952 - Alexander , et al. June 14, 2 | 2022-06-14 |
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
Grant 11,292,796 - Elsner , et al. April 5, 2 | 2022-04-05 |
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20200262840 - ELSNER; Jan ; et al. | 2020-08-20 |
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
Grant 10,683,298 - Elsner , et al. | 2020-06-16 |
Substituted 4-aminoisoindoline-1,3-dione Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20190322647 - Alexander; Matthew D. ; et al. | 2019-10-24 |
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20190077806 - ELSNER; Jan ; et al. | 2019-03-14 |
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
Grant 10,167,290 - Elsner , et al. J | 2019-01-01 |
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20170342080 - ELSNER; Jan ; et al. | 2017-11-30 |
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
Grant 9,795,607 - Calabrese , et al. October 24, 2 | 2017-10-24 |
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
Grant 9,771,371 - Elsner , et al. September 26, 2 | 2017-09-26 |
Substituted Pyrrolopyrimidine Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20160324861 - Calabrese; Andrew Antony ; et al. | 2016-11-10 |
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
Grant 9,428,509 - Calabrese , et al. August 30, 2 | 2016-08-30 |
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
Grant 9,346,812 - Calabrese , et al. May 24, 2 | 2016-05-24 |
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20160024101 - ELSNER; Jan ; et al. | 2016-01-28 |
Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
Grant 9,193,692 - Perrin-Ninkovic , et al. November 24, 2 | 2015-11-24 |
Methods of synthesis and purification of heteroaryl compounds
Grant 9,079,900 - Harris , et al. July 14, 2 | 2015-07-14 |
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20150051397 - Perrin-Ninkovic; Sophie ; et al. | 2015-02-19 |
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
Grant 8,907,087 - Perrin-Ninkovic , et al. December 9, 2 | 2014-12-09 |
Substituted Pyrrolopyrimidine Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20140200207 - Calabrese; Andrew Antony ; et al. | 2014-07-17 |
Substituted Pyrrolopyrimidine Compounds, Compositions Thereof, And Methods Of Treatment Therewith
App 20140200206 - Calabrese; Andrew Antony ; et al. | 2014-07-17 |
Methods Of Synthesis And Purification Of Heteroaryl Compounds
App 20140155593 - Harris; Roy L. ; et al. | 2014-06-05 |
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20130289271 - Perrin-Ninkovic; Sophie ; et al. | 2013-10-31 |
Methods of synthesis and purification of heteroaryl compounds
Grant 8,569,494 - Harris , et al. October 29, 2 | 2013-10-29 |
Methods Of Synthesis And Purification Of Heteroaryl Compounds
App 20130245254 - Harris; Roy L. ; et al. | 2013-09-19 |
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway
Grant 8,507,492 - Perrin-Ninkovic , et al. August 13, 2 | 2013-08-13 |
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
Grant 8,492,381 - Perrin-Ninkovic , et al. July 23, 2 | 2013-07-23 |
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20120071658 - Perrin-Ninkovic; Sophie ; et al. | 2012-03-22 |
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20120059164 - Perrin-Ninkovic; Sophie ; et al. | 2012-03-08 |
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
Grant 8,110,578 - Perrin-Ninkovic , et al. February 7, 2 | 2012-02-07 |
Methods Of Synthesis And Purification Of Heteroaryl Compounds
App 20110137028 - Harris; Roy L. ; et al. | 2011-06-09 |
mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
App 20100216781 - Perrin-Ninkovic; Sophie ; et al. | 2010-08-26 |
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
App 20080242694 - D'Sidocky; Neil R. ; et al. | 2008-10-02 |
| 